Thus, CRP ≥ 2 mg/L 1 month post-index hospitalization for STEMI in our patients with the most adverse outcome (i.e., LVSD6M alone or also with HF hospitalization long term) is consistent with a persistent inflammatory response post-STEMI. The gene discussed is CRP; the disease is hydrops fetalis.